125 related articles for article (PubMed ID: 1468144)
1. Impaired synthesis of taurine in a patient with tyrosinemia type I during the oral L-methionine loading test.
Valík D; Klusácek D; Pintera J
Clin Chim Acta; 1992 Sep; 210(3):227-9. PubMed ID: 1468144
[No Abstract] [Full Text] [Related]
2. Deficiency of fumarylacetoacetase in a patient with hereditary tyrosinemia.
Berger R; Smit GP; Stoker-de Vries SA; Duran M; Ketting D; Wadman SK
Clin Chim Acta; 1981 Jul; 114(1):37-44. PubMed ID: 7249373
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of deuterated metabolites in patients with tyrosinemia type I after oral loading with deuterated L-tyrosine.
Wadman SK; Duran M; Ketting D; Bruinvis L; van Sprang FJ; Berger R; Smit GP; Steinmann B; Leonard JV; Divry P; Farriaux JP; Cartigny B
Clin Chim Acta; 1983 May; 130(2):231-8. PubMed ID: 6872257
[TBL] [Abstract][Full Text] [Related]
4. Neonatal and prenatal diagnosis of hereditary tyrosinaemia.
King GS; MacKenzie F; Pettit BR
Lancet; 1983 Jun; 1(8336):1279. PubMed ID: 6134070
[No Abstract] [Full Text] [Related]
5. Urinary excretion of succinylacetone and delta-aminolevulinic acid in patients with hereditary tyrosinemia.
Christensen E; Jacobsen BB; Gregersen N; Hjeds H; Pedersen JB; Brandt NJ; Baekmark UB
Clin Chim Acta; 1981 Nov; 116(3):331-41. PubMed ID: 7296896
[TBL] [Abstract][Full Text] [Related]
6. Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts.
Manabe S; Sassa S; Kappas A
J Exp Med; 1985 Sep; 162(3):1060-74. PubMed ID: 3928801
[TBL] [Abstract][Full Text] [Related]
7. Hematin therapy for the neurologic crisis of tyrosinemia.
Rank JM; Pascual-Leone A; Payne W; Glock M; Freese D; Sharp H; Bloomer JR
J Pediatr; 1991 Jan; 118(1):136-9. PubMed ID: 1986081
[No Abstract] [Full Text] [Related]
8. [Tyrosinemia].
Salo MK
Duodecim; 1992; 108(9):841-3. PubMed ID: 1366298
[No Abstract] [Full Text] [Related]
9. Tyrosinaemia type Ia without excess of urinary succinylacetone.
Biasucci G; Giuffré B; La Grutta S; Riva E
J Inherit Metab Dis; 1993; 16(6):1056-7. PubMed ID: 8127063
[No Abstract] [Full Text] [Related]
10. [Sepsis, as the presenting form of hereditary tyrosinemia type I].
Iglesias Niubo J; Riudor Taravilla E; Goma Brufau AR; Civit Colas MA; Suñé Gracia JM; Bertrán Sanges JM; Gallart Catalá A
An Esp Pediatr; 1988 Sep; 29(3):235-8. PubMed ID: 3057981
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of succinylacetone after homogentisate and tyrosine loading in healthy individuals with low fumarylacetoacetase activity.
Kvittingen EA; Leonard JV; Pettit BR; King GS
Clin Chim Acta; 1985 Nov; 152(3):271-9. PubMed ID: 4064334
[TBL] [Abstract][Full Text] [Related]
12. The pre- and post-natal diagnosis of tyrosinemia type I and the detection of the carrier state by assay of fumarylacetoacetase.
Kvittingen EA; Brodtkorb E
Scand J Clin Lab Invest Suppl; 1986; 184():35-40. PubMed ID: 3473612
[TBL] [Abstract][Full Text] [Related]
13. Cholestasis and hypermethioninemia during dietary management of hereditary tyrosinemia type 1.
Ameen VZ; Powell GK; Rassin DK
J Pediatr; 1986 Jun; 108(6):949-52. PubMed ID: 2872285
[No Abstract] [Full Text] [Related]
14. Identification of 4,6-dioxoheptanoic acid (succinylacetone), 3,5-dioxooctanedioic acid (succinylacetoacetate) and 4-Oxo-6-hydroxyheptanoic acid in the urine from patients with hereditary tyrosinemia.
Lindblad B; Steen G
Biomed Mass Spectrom; 1982 Oct; 9(10):419-24. PubMed ID: 7171740
[TBL] [Abstract][Full Text] [Related]
15. Prenatal diagnosis of hereditary tyrosinemia.
Steinmann B; Gitzelmann R; Kvittingen EA; Stokke O
N Engl J Med; 1984 Mar; 310(13):855-6. PubMed ID: 6700679
[No Abstract] [Full Text] [Related]
16. Prenatal diagnosis of tyrosinaemia type I by use of stable isotope dilution mass spectrometry.
Jakobs C; Kvittingen EA; Berger R; Haagen A; Kleijer W; Niermeijer M
Eur J Pediatr; 1985 Jul; 144(2):209-10. PubMed ID: 4043138
[No Abstract] [Full Text] [Related]
17. [Dietary management of hereditary tyrosinemia. Apropos of 7 cases].
Jehan P; Buchman M; Odièvre M
Ann Pediatr (Paris); 1984 Jan; 31(1):33-40. PubMed ID: 6712098
[No Abstract] [Full Text] [Related]
18. The human fumarylacetoacetase gene: characterisation of restriction fragment length polymorphisms and identification of haplotypes in tyrosinemia type 1 and pseudodeficiency.
Rootwelt H; Kvittingen EA; Høie K; Agsteribbe E; Hartog M; van Faassen H; Berger R
Hum Genet; 1992 May; 89(2):229-33. PubMed ID: 1350265
[TBL] [Abstract][Full Text] [Related]
19. Early diagnosis of tyrosinemia type II.
Heidemann DG; Dunn SP; Bawle EV; Shepherd DM
Am J Ophthalmol; 1989 May; 107(5):559-60. PubMed ID: 2712144
[No Abstract] [Full Text] [Related]
20. Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1.
Bain MD; Purkiss P; Jones M; Bingham P; Stacey TE; Chalmers RA
Eur J Pediatr; 1990 Jun; 149(9):637-9. PubMed ID: 2373116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
